Bradbury Daniel
SEC-identified person · CIK 1236397 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Vivani Medical, Inc. VANI | Director | filed 2024 - 2026 |
| Castle Biosciences INC CSTL | Director | filed 2019 - 2026 |
| Equillium, Inc. EQ | Director · Executive Chairman | filed 2018 - 2026 |
| Intercept Pharmaceuticals, INC. ICPT | Director | filed 2016 - 2023 |
| Panacea Acquisition Corp PANA | Director | filed 2020 - 2021 |
| Geron Corp GERN | Director | filed 2012 - 2019 |
| Corcept Therapeutics INC CORT | Director | filed 2012 - 2019 |
| Illumina, INC. ilmn#456 | Director | filed 2006 - 2017 |
| Biomed Realty Trust Inc BMR | Director | filed 2013 - 2016 |
| Biomed Realty L P | Director | filed 2013 - 2013 |
| Amylin Pharmaceuticals INC AMLN | Director · President & Chief Operating | filed 2006 - 2012 |
| Transcept Pharmaceuticals Inc TSPT | Director | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.